Novel genetic experiment shrinks tough-to-treat cancer
In this Article:
- In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers at Providence turbocharged her own immune cells, highlighting a possible new way to someday treat a variety of cancers
- The research, published in the New England Journal of Medicine, explores a new method of harnessing the immune system to create “living drugs” able to seek and destroy tumors
“It’s an approach known as T cell receptor, or TCR, therapy. The research remains highly experimental, but Wilkes’ remarkable response provides me with optimism that we’re on the right track.” —Eric Tran, Ph.D., Assistant Member, Adoptive Cell Therapy Laboratory, Earle A. Chiles Research Institute
Read the full article, originally published in AP News, June 2022.